Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Stephen G Chun"'
Autor:
Hari Menon, Dawei Chen, Rishab Ramapriyan, Maria Angelica Cortez, Hampartsoum B Barsoumian, Ahmed I Younes, Quynh-Nhu Nguyen, Nathan I Comeaux, Mauricio S Caetano, Taylor R Cushman, Jonathan E Schoenhals, Timothy P Reilly, Fatemeh Masrorpour, Ailin Li, Stephen G Chun
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Despite some successes with checkpoint inhibitors for treating cancer, most patients remain refractory to treatment, possibly due to the inhibitory nature of the tumor stroma that impedes the function and entry of effector cells. We devise
Externí odkaz:
https://doaj.org/article/a6974833715940429eb0dcc8b93bbb3f
Autor:
David L Schwartz, Alan Sosa, Stephen G Chun, Chiuxiong Ding, Xian-Jin Xie, Lucien A Nedzi, Robert D Timmerman, Baran D Sumer
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0172055 (2017)
To confirm safety and feasibility of hypofractionated SBRT for early-stage glottic laryngeal cancer.Twenty consecutive patients with cTis-T2N0M0 carcinoma of glottic larynx were enrolled. Patients entered dose-fractionation cohorts of incrementally s
Externí odkaz:
https://doaj.org/article/945e0ede1ac74c2ba3a0e981f5b406d9
Autor:
G. Brandon Gunn, MD, Adam S. Garden, MD, Rong Ye, MSc, Noveen Ausat, BA, Kristina R. Dahlstrom, PhD, William H. Morrison, MD, C. David Fuller, MD, PhD, Jack Phan, MD, PhD, Jay P. Reddy, MD, PhD, Shalin J. Shah, MD, Lauren L. Mayo, MD, Stephen G. Chun, MD, Gregory M. Chronowski, MD, Amy C. Moreno, MD, Jeffery N. Myers, MD, PhD, Ehab Y. Hanna, MD, Bita Esmaeli, MD, Maura L. Gillison, MD, PhD, Renata Ferrarotto, MD, Katherine A. Hutcheson, PhD, Mark S. Chambers, DMD, MS, Lawrence E. Ginsberg, MD, Adel K. El-Naggar, MD, PhD, David I. Rosenthal, MD, Xiaorong Ronald Zhu, PhD, Steven J. Frank, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 108-118 (2021)
Purpose: To characterize our experience and the disease control and toxicity of proton therapy (PT) for patients with head and neck cancer (HNC). Patients and Methods: Clinical outcomes for patients with HNC treated with PT at our institution were pr
Externí odkaz:
https://doaj.org/article/a36cc224ecfa4ccab274371253faf9db
Autor:
Kelsey L. Corrigan, MD, MPH, Xiudong Lei, PhD, Neelofur Ahmad, MD, Isidora Arzu, MD, PhD, Elizabeth Bloom, MD, Stephen G. Chun, MD, Chelain Goodman, MD, PhD, Karen E. Hoffman, MD, MHSc, MPH, Melissa Joyner, MD, Lauren Mayo, MD, Melissa Mitchell, MD, PhD, Kevin T. Nead, MD, MPhil, George H. Perkins, MD, Valerie Reed, MD, Jay P. Reddy, MD, PhD, Pamela Schlembach, MD, Simona F. Shaitelman, MD, EdM, Michael C. Stauder, MD, Eric A. Strom, MD, Welela Tereffe, MD, MPH, Lee Wiederhold, MD, PhD, Wendy A. Woodward, MD, PhD, Benjamin D. Smith, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 2, Pp 100877- (2022)
Introduction: The first high-quality clinical trial to support ultrahypofractionated whole-breast irradiation (ultra-HF-WBI) for invasive early-stage breast cancer (ESBC) was published in April 2020, coinciding with the beginning of the COVID-19 pand
Externí odkaz:
https://doaj.org/article/1dfa7014977d4dfd8f9ad53d61be0d8f
Autor:
Alexander D. Sherry, Tharakeswara K. Bathala, Suyu Liu, Bryan M. Fellman, Stephen G. Chun, Nikesh Jasani, B. Ashleigh Guadagnolo, Anuja Jhingran, Jay P. Reddy, Paul G. Corn, Amishi Y. Shah, Kelsey W. Kaiser, Amol J. Ghia, Daniel R. Gomez, Chad Tang
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:910-918
The benefit of local consolidative therapy (LCT) for oligometastasis across histologies remains uncertain. EXTernal beam radiation to Eliminate Nominal metastatic Disease (EXTEND; NCT03599765) is a randomized phase 2 basket trial evaluating the effec
Autor:
Stephen G. Chun, Andreas Rimner, Arya Amini, Joe Y. Chang, Jessica Donington, Martin J. Edelman, Yimin Geng, Matthew A. Gubens, Kristin A. Higgins, Puneeth Iyengar, Benjamin Movsas, Matthew S. Ning, Henry S. Park, George Rodrigues, Andrea Wolf, Charles B. Simone
Publikováno v:
JAMA Oncology.
ImportanceThymic carcinoma is rare, and its oncologic management is controversial due to a paucity of prospective data. For this reason, multidisciplinary consensus guidelines are crucial to guide oncologic management.ObjectiveTo develop expert multi
Autor:
Chad Tang, Alexander D. Sherry, Cara Haymaker, Tharakeswara Bathala, Suyu Liu, Bryan Fellman, Lorenzo Cohen, Ana Aparicio, Amado J. Zurita, Alexandre Reuben, Enrica Marmonti, Stephen G. Chun, Jay P. Reddy, Amol Ghia, Sean McGuire, Eleni Efstathiou, Jennifer Wang, Jianbo Wang, Patrick Pilie, Craig Kovitz, Weiliang Du, Samantha J. Simiele, Rachit Kumar, Yerko Borghero, Zheng Shi, Brian Chapin, Daniel Gomez, Ignacio Wistuba, Paul G. Corn
Publikováno v:
JAMA Oncology.
ImportanceDespite evidence demonstrating an overall survival benefit with up-front hormone therapy in addition to established synergy between hormone therapy and radiation, the addition of metastasis-directed therapy (MDT) to hormone therapy for olig
Autor:
John S. Yordy, David A. Boothman, Baran D. Sumer, Xian-Jin Xie, Gaurab Chakrabarti, Jingsheng Yan, Joel Thibodeaux, William G. Bornmann, Stephen G. Chun, Hyunsil Park, Shuangping Liu, Zhen-Hua Lin, Srilakshmi Reddy, Long-Shan Li
Supplemental Figure Legends; Supplemental Table Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73dc9f467bf254d611189a2a2b256fcd
https://doi.org/10.1158/1535-7163.22507567
https://doi.org/10.1158/1535-7163.22507567
Autor:
John S. Yordy, David A. Boothman, Baran D. Sumer, Xian-Jin Xie, Gaurab Chakrabarti, Jingsheng Yan, Joel Thibodeaux, William G. Bornmann, Stephen G. Chun, Hyunsil Park, Shuangping Liu, Zhen-Hua Lin, Srilakshmi Reddy, Long-Shan Li
Supplemental Figure 1. Elevated NQO1 expression in patients with HNC correlates with poor overall survival to standard therapy; Supplemental Figure 2. Functional shRNA-NQO1 knockdown rescues β-lapinduced cell death; Supplemental Figure 3. β-Lap-ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f23c044022b95ee1080e8df4787ffc3
https://doi.org/10.1158/1535-7163.22507564
https://doi.org/10.1158/1535-7163.22507564
Autor:
Brooke C. Bloom, Alexander Augustyn, Todd A. Pezzi, Hari Menon, Lauren L. Mayo, Shalin J. Shah, David L. Schwartz, Steven J. Chmura, Faye M. Johnson, James W. Welsh, Stephen G. Chun
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Merkel cell carcinoma has historically had dismal prognosis with limited cytotoxic chemotherapy options that provide durable control of metastatic disease. The advent of anti-programmed death protein (anti-PD1)/anti-programmed death-ligand 1 (anti-PD
Externí odkaz:
https://doaj.org/article/517414ba97be4b40bff6df40bf6ee72d